← Leaderboards
Peter A. Rice
Univ Of Massachusetts Med Sch Worcester
$21,957,165
Attributed
$32,338,175
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$48,378,379 · 16
By mechanism
U19$22,310,266 · 5
R01$16,508,273 · 5
R37$6,069,600 · 1
R33$1,434,029 · 1
R61$1,019,023 · 1
R56$583,230 · 1
Top collaborators
- Sanjay Ram21 shared
- Keith Wycoff10 shared
- John A Moss5 shared
- Sunita Gulati4 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Sanjay Ram$21,500,867
- Jutamas Shaughnessy$429,025
- Lisa Ann Lewis$513,036
Others in their field
Top investigators on “Neisseria Gonorrhoeae”
- H. Steven Seifert · Northwestern University$22,507,026
- Sanjay Ram · Univ Of Massachusetts Med Sch Worcester$17,986,057
- Jay B Jackson · Johns Hopkins University$17,529,470
- Cynthia Nau Cornelissen · Virginia Commonwealth University$15,969,202
- William Maurice Shafer · Veterans Health Administration$14,813,541
- Alison K Criss · Northwestern University$12,931,436
Research focus
Neisseria GonorrhoeaeInfectionLipooligosaccharideGonorrheaSexually Transmitted DiseasesBactericideComplementComplement Factor HResistanceInfertilityIn VivoVaccine CandidateComplement 4b-Binding ProteinEpitopesTransgenic MicePelvic Inflammatory DiseaseSurfacePathogenWomanVaccinesBaseEctopic PregnancyComplement InactivatorsAntibiotics
Grant awards (64)
A novel vaccine against multidrug-resistant gonorrhea$298,787
R01 · FY2023 · AI
A novel vaccine against multidrug-resistant gonorrhea$653,148
R01 · FY2022 · AI
Gonorrhea and HIV prevention with intravaginal ring drug delivery$477,355
R33 · FY2022 · AI
A novel vaccine against multidrug-resistant gonorrhea$1,227,829
R01 · FY2021 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea$862,755
R01 · FY2021 · AI
Gonorrhea and HIV prevention with intravaginal ring drug delivery$475,901
R33 · FY2021 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea$1,170,759
R01 · FY2020 · AI
A novel vaccine against multidrug-resistant gonorrhea$1,133,414
R01 · FY2020 · AI
Gonorrhea and HIV prevention with intravaginal ring drug delivery$480,773
R33 · FY2020 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea$1,118,405
R01 · FY2019 · AI
A novel vaccine against multidrug-resistant gonorrhea$967,287
R01 · FY2019 · AI
Immune defenses against Neisseria gonorrhoeae$629,859
R01 · FY2019 · AI · contact PI
Gonorrhea and HIV prevention with intravaginal ring drug delivery$495,740
R61 · FY2019 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea$1,051,980
R01 · FY2018 · AI
Immune defenses against Neisseria gonorrhoeae$629,859
R01 · FY2018 · AI · contact PI
Gonorrhea and HIV prevention with intravaginal ring drug delivery$523,283
R61 · FY2018 · AI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2018 · AI · contact PI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea$1,250,425
R01 · FY2017 · AI
Immune defenses against Neisseria gonorrhoeae$629,859
R01 · FY2017 · AI · contact PI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2017 · AI · contact PI
Immune defenses against Neisseria gonorrhoeae$629,859
R01 · FY2016 · AI · contact PI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2016 · AI · contact PI
Immune defenses against Neisseria gonorrhoeae$629,859
R01 · FY2015 · AI · contact PI
Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae$449,255
R01 · FY2015 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$583,230
R56 · FY2014 · AI · contact PI
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection$2,460,642
U19 · FY2013 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$626,569
R37 · FY2013 · AI · contact PI
Experimental and human protective immunity to Neisseria gonorrhoeae$329,157
U19 · FY2013 · AI · contact PI
Administrative Core$111,464
U19 · FY2013 · AI · contact PI
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection$2,768,529
U19 · FY2012 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$666,562
R37 · FY2012 · AI · contact PI
Experimental and human protective immunity to Neisseria gonorrhoeae$338,523
U19 · FY2012 · AI · contact PI
Administrative Core$97,351
U19 · FY2012 · AI · contact PI
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection$2,574,877
U19 · FY2011 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$670,127
R37 · FY2011 · AI · contact PI
Experimental and human protective immunity to Neisseria gonorrhoeae$404,366
U19 · FY2011 · AI · contact PI
Administrative Core$150,913
U19 · FY2011 · AI · contact PI
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection$2,595,567
U19 · FY2010 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$676,358
R37 · FY2010 · AI · contact PI
Experimental and human protective immunity to Neisseria gonorrhoeae$292,756
U19 · FY2010 · AI · contact PI
Administrative Core$151,716
U19 · FY2010 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$83,525
R37 · FY2010 · AI · contact PI
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection$2,681,405
U19 · FY2009 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$665,016
R37 · FY2009 · AI · contact PI
Experimental and human protective immunity to Neisseria gonorrhoeae$291,437
U19 · FY2009 · AI · contact PI
Administrative Core$148,011
U19 · FY2009 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$549,530
R37 · FY2008 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$547,625
R37 · FY2007 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$551,010
R37 · FY2006 · AI · contact PI
Immunology of Infection with Neisseria gonorrhoeae$521,820
R37 · FY2005 · AI
Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia$2,370,307
U19 · FY2004 · AI
Immunology of Infection with Neisseria gonorrhoeae$511,458
R37 · FY2004 · AI
Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia$1,584,061
U19 · FY2003 · AI
IMMUNOLOGY OF INFECTION WITH NEISSERIA GONORRHOEAE$474,492
R01 · FY2003 · AI
Training Program in Host Pathogen Interactions$268,338
T32 · FY2003 · AI
SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEARCH CENTE$962,724
U19 · FY2002 · AI
IMMUNOLOGY OF INFECTION WITH NEISSERIA GONORRHOEAE$462,459
R01 · FY2002 · AI
Training Program in Host Pathogen Interactions$127,695
T32 · FY2002 · AI
SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEARCH CENTE$1,002,327
U19 · FY2001 · AI
IMMUNOLOGY OF INFECTION WITH NEISSERIA GONORRHOEAE$450,779
R01 · FY2001 · AI
STRUCTURAL DETERMINATION OF NEISSERIA GONORRHOEAE OLIGOSACCHARIDES FROM ISOLATES$53,566
P41 · FY2001 · RR
SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEARCH CENTE$994,133
U19 · FY2000 · AI
IMMUNOLOGY OF INFECTION WITH NEISSERIA GONORRHOEAE$439,439
R01 · FY2000 · AI
STRUCTURAL DETERMINATION OF NEISSERIA GONORRHOEAE OLIGOSACCHARIDES FROM ISOLATES$4,359
P41 · FY2000 · RR